Literature DB >> 34178807

Seroprevalence of Cystic Echinococcosis Using Recombinant Antigen B-ELISA in North Khorasan Province, Northeast of Iran.

Reza Shafiei1,2, Fatemeh Taghasi3, Seyed Ahmad Hashemi2, Yaser Panahi4, Nasir Arefkhah5, Mostafa Omidian6, Farzane Arianfar7, Zohreh Mostafavi-Pour7, Bahador Sarkari8.   

Abstract

BACKGROUND: Cystic echinococcosis (CE) is one of the most important helminthic parasitic diseases in Iran. The current study aimed to assess the seroprevalence of CE in North Khorasan Province, Northeast of Iran in 2018.
METHODS: The study was carried out in seven cities of North Khorasan Province. Venous blood samples were collected from 932 individuals referring to health centers of those seven cities. A questionnaire was used to obtain the data regarding the subject's gender, age, residence and risk factors linked to the hydatid cyst. Sera samples were evaluated for anti-hydatid cyst antibodies in an ELISA system, using a recombinant B8/1 antigen of E. granulosus.
RESULTS: Of the 932 recruited subjects, 496 (53.2%) were male and 436 (46.8%) were female. The range of participants' age was between 11 to 83 yr old and the mean age of the subjects was 35.4 (±12.7) years. Anti-hydatid cyst antibodies were detected in the sera of 37 out of 932 subjects, corresponding to a seroprevalence rate of 3.96%. From these, 20 (54.05%) were male and 17 (45.95%) were female. There were no associations between seropositivity to hydatid cyst and age, the gender of the participants, residential areas and having contact with dogs (P>0.05).
CONCLUSION: CE is relatively prevalent throughout the North Khorasan Province in the Northeast of Iran. Rate of CE infection in this Province is somewhat similar to the rate of infection in other parts of the country.
Copyright © 2021 Shafiei et al. Published by Tehran University of Medical Sciences.

Entities:  

Keywords:  Cystic echinococcosis; Iran; Seroprevalence

Year:  2021        PMID: 34178807      PMCID: PMC8214599          DOI: 10.18502/ijph.v50i3.5605

Source DB:  PubMed          Journal:  Iran J Public Health        ISSN: 2251-6085            Impact factor:   1.429


Introduction

Cystic echinococcosis (CE) is a zoonotic infection of humans and domestic animals caused by the larval stages of the dog tapeworm Echinococcus granulosus. The human becomes infected through ingestion of foods contaminated with the E. granulosus egg defecated from infected dogs (1). CE is the most important chronic zoonotic helminthic infection with high prevalence in humans and livestock in some areas of the world with economic and public health impacts. The greatest prevalence of CE in human and animal hosts is found in countries of the temperate zones, including several parts of Eurasia (the Mediterranean regions, southern and central parts of Russia, central Asia, and China), Australia, some parts of America (especially South America) and north and east Africa. The diseases are a serious health problem in the Mediterranean region, especially in countries in the Middle East including Turkey and Iran (1, 2). The seroprevalence rate of human CE in Iran varies from 1.6% up to more than 20% and the pooled seroprevalence of CE has been estimated at 6.0% (3–6). Seroprevalence rates of CE in Iran have been reported to be 3.4% in Alborz Province in central Iran, 2.6% in Lorestan Province in the west, 1.79% in Meshkin-Shahr in the Northwest and 7.2% in the Yasuj area in the southwest of the country (5, 7–9). The number of surgeries due to CE in Iran has been reported to be 1300 cases (10). Native antigen B has been used in most of the studies about the seroprevalence of CE. This antigen is appropriate in the diagnosis of hydatid cysts (11). In the present study, a recombinant antigen from one of the antigen B subunits has been used (12). This antigen has a slightly higher sensitivity and specificity than the native antigen B in the diagnosis of CE. Accordingly, this antigen was used in this study and a similar study regarding the seroprevalence of hydatid cyst in children in a rural area in Fars Province (13). As there is no available data on the seroprevalence of CE in North Khorasan Province, northeast Iran, the present study aimed to assess the seroprevalence of CE in this area.

Materials and Methods

Study area and sampling

The study was carried out in 2018 in seven cities of North Khorasan Province, including Bojnurd, Shirvan, Maneh and Samalghan, Faruj, Raz and Jargaran, Garmeh and Jajarm (Fig. 1).
Fig. 1:

Map of Iran showing North Khorasan Province and its counties

Map of Iran showing North Khorasan Province and its counties North Khorasan is of the 31 provinces of Iran located in northeastern of the country and Bojnurd is the capital of the province. North Khorasan covers an area of 28,434 km2 and has a population of 850,000. The geographical coordinates of the province are 37°28’34”N and 57°19’54”E. North Khorasan holds diverse climate including the cities that enjoy moderate mountain climate and cities that face the desert. The population living in this area is living mainly on farming and animal husbandry. Venous whole blood samples (about 5 mL) were collected from 932 individuals referring to health centers of the aforementioned cities. Sera were separated from the blood samples and kept at −20 °C till use. The enrollment criteria were being the resident of the studied area and having no infectious diseases, while the exclusion criteria were having a fever, normally not feeling healthy, and unwilling to provide the blood. Through sampling, a questionnaire was used to obtain the data regarding the subject’s gender, age, residence and risk factors linked to the hydatid cyst such as having contact with the dog.

Detection of anti-hydatid cyst antibodies

Sera samples were evaluated for anti-hydatid cyst antibodies in an ELISA system, using a recombinant B8/1 antigen of E. granulosus (12). The ELISA was performed in Department of Parasitology and Mycology at Shiraz University of Medical Sciences, Shiraz, Iran. Briefly, the ELISA, flat-bottom 96-well microplates were coated (100 μL/well) with 5 μg/mL of the recombinant antigen in coating buffer. Unbound antigens were removed by washing buffer and blocking was performed, using 3% skimmed milk. Serum samples were added to the plates and the plates were washed after 2 hours. Horseradish peroxidaseconjugated anti-human antibody was added to the plates and were then washed after 1.5 hours. The substrate was added to the plate and the absorbance was measured positive sera (from pathologically confirmed hydatid cyst patients) along with sera from healthy controls were applied in each run of ELISA and the cutoff point was set at 2 standard deviations (SD) above the mean OD of the negative control samples.

Statistical analyses

Statistical analysis of the data was performed using SPSS (ver. 18, Chicago, IL, USA). The association between the seropositivity to hydatid cyst and the subjects’ demographic features and also the risk factors for the infection were verified, utilizing the Chi-Square statistic.

Ethical approval

The study was approved by the Ethical Review Committee of North Khorasan University of Medical Sciences (ethical code: IR.NKUMS.Med.REC.1395.41). Informed consent was obtained from each participant.

Results

Of the 932 recruited subjects, 496 (53.2%) were male and 436 (46.8%) were female. The range of participants’ age was between 11 to 83 yr old and the mean age of the subjects was 35.4 (±12.7) years. Most of the subjects (36.81%) were in the age group 21–30 yr old. Anti-hydatid cyst antibodies were detected in the sera of 37 out of 932 subjects, corresponding to a seroprevalence rate of 3.96%. From these, 20 (54.05%) were male and 17 (45.95%) were female. Seropositivity to hydatid cyst was more prevalent in the age group of 21–30 yr (43.2%), however, there were no associations between seropositivity to hydatid cyst and age of the participants. Moreover, no statistically significant difference was seen between seropositivity to hydatid cyst infection and gender of the participants (P>0.05). Residential areas and having contact with dogs had no significant influence on the risk of hydatid cyst seropositivity. Table 1 shows the demographic features and relative seropositivity to hydatid cyst in the studied subjects in seven cities of North Khorasan Province, northeast of Iran.
Table 1:

Demographic features and relative seropositivity to hydatid cyst among people living in seven cities of North Khorasan Province, Northeast of Iran

CharacteristicsFrequencyPercentPositive for anti-hydatid cyst antibodiesP-value
Frequency (No.)Percent (%)
Sex
Male49653.22054.05P>0.05
Female43646.81745.95
Age group (yr)
<20646.8725.4
21–3034336.811643.25
31–4025126.931027.03
41–5013614.59718.92P>0.05
51–60919.7625.4
>60475.0400
Residence
Bojnurd410443081.08
Shirvan14715.838.1
Maneh and Samalghan495.300
Faruj768.2410.82P>0.05
Raz and Jargaran768.200
Garmeh909.700
Jajarm84900
Contact to dog
Yes21122.631540.54P>0.05
No72177.372259.46
Demographic features and relative seropositivity to hydatid cyst among people living in seven cities of North Khorasan Province, Northeast of Iran

Discussion

Hydatid cyst is a common zoonotic disease in many countries around the world. According to the WHO report, Iran, Iraq, and Turkey are among the hyper endemic areas for hydatid cysts infection in the Middle East. In Iran, hydatid cyst is one of the most important helminthic parasitic diseases and infection with E. granulosus is very common in final hosts in different areas of the country. In Iran, the rate of E. granulosus infection in dogs varies from 2.2% up to 63.2% in different areas of the country. High prevalence of E. granulosus infection in dogs ensures contamination of soil and vegetables and ultimately transmission of the infection to humans. The overall annual cost of CE in Iran was estimated at US$232.3 million, including both direct and indirect costs. The cost associated with human CE was estimated at US$93.39 million and the annual cost associated with CE in livestock was estimated at US$132 million (10). The findings of the current study revealed a seroprevalence rate of 3.96% for CE in North Khorasan province in Iran. The rate is somewhat similar to those reported in other parts of the country in previous studies (7, 9, 18–19). However, the seroprevalence rate in the current study was higher than those reported in Ilam, Hamedan, Isfahan, Zanjan, East Azerbaijan, Ardabil, and Kurdistan in Iran, which ranged from 0.23% to 3.6% (5, 20–22). The rate of infection in males and females were almost the same in our study. This indicated that both men and women are equally prone to E. granulosus infection. The reason for this is that dogs are roaming around in all areas and through contaminating the environment, causes human infection, regardless of gender. Most of the previous studies in Iran have not revealed a specific difference between the sexes and hydatid cyst infection (4, 5, 13, 23). In Arak, central Iran, the rate of infection in females (3.99%) was higher than males (2.26%), but there was no significant statistical difference between infection rate of males and females (15). In Chaharmahal and Bakhtiari Province, southwestern Iran, females had a higher rate of CE infection than males (5.1% in females and 4.4% in males), without any significant statistical difference (24). However, in Khorramabad, capital of Lorestan Province in western Iran, CE was reported to be more prevalent in males (60%) than females (40%) and the difference between infection rate of males and females was significant (25). In our study, there was no significant difference between the rate of infection in different age groups and the disease was fairly prevalent in all age groups. This disease can infect all people of any age and all people are at risk of infection. A large percentage of the adult hydatid cyst results from childhood infection. The seroprevalence of hydatid cyst in children in a rural community in Fars province, southern Iran has been reported to be 6.7% (13). In our study, 5.4% of young people were found to be seropositive for CE, which is somewhat similar to the rate reported in children in southern Iran. Our study was done in seven cities of North Khorasan Province including Bojnurd, Shirvan, Maneh and Samalghan, Faruj, Raz and Jargaran, Garmeh and Jajarm. Although the prevalence of CE infection in these cities was somewhat different, there was no statistically significant difference between infection rates in different cities, which indicates that the disease is fairly prevalent throughout the province.

Conclusion

CE is relatively prevalent throughout the North Khorasan Province. Rate of CE infection in this Province is fairly similar to the rate of infection in other parts of the country.

Ethical considerations

Ethical issues (including plagiarism, informed consent, misconduct, data fabrication and/or falsification, double publication and/or submission, redundancy, etc.) have been completely observed by the authors.
  16 in total

1.  Immunodiagnostic Value of Echinococcus Granulosus Recombinant B8/1 Subunit of Antigen B.

Authors:  Amir Savardashtaki; Bahador Sarkari; Farzane Arianfar; Zohreh Mostafavi-Pour
Journal:  Iran J Immunol       Date:  2017-06       Impact factor: 1.603

2.  Echinococcosis: Control and Prevention.

Authors:  P S Craig; D Hegglin; M W Lightowlers; P R Torgerson; Q Wang
Journal:  Adv Parasitol       Date:  2016-12-28       Impact factor: 3.870

Review 3.  The seroprevalence rate and population genetic structure of human cystic echinococcosis in the Middle East: A systematic review and meta-analysis.

Authors:  Tahereh Mikaeili Galeh; Adel Spotin; Mahmoud Mahami-Oskouei; David Carmena; Mohammad Taghi Rahimi; Aleksandra Barac; Roghayeh Ghoyounchi; Reza Berahmat; Ehsan Ahmadpour
Journal:  Int J Surg       Date:  2018-02-03       Impact factor: 6.071

Review 4.  Immunodiagnosis of human hydatid disease: Where do we stand?

Authors:  Bahador Sarkari; Zahra Rezaei
Journal:  World J Methodol       Date:  2015-12-26

5.  Seroepidemiological study of cystic echinococcosis in nomadic communities in the southwest of Iran: A population-based study.

Authors:  Abdolali Moshfe; Bahador Sarkari; Nasir Arefkhah; Reza Nikbakht; Reza Shahriarirad; Zahra Rezaei; Ali Jamshidi; Farid Moradian
Journal:  J Immunoassay Immunochem       Date:  2018-11-21

6.  The serological study of cystic echinococcosis and assessment of surgical cases during 5 years (2007-2011) in Khorram Abad, Iran.

Authors:  M Zibaei; A Azargoon; M Ataie-Khorasgani; K Ghanadi; S M Sadjjadi
Journal:  Niger J Clin Pract       Date:  2013 Apr-Jun       Impact factor: 0.968

7.  Seroepidemiological study of human hydatidosis in meshkinshahr district, ardabil province, iran.

Authors:  Z Heidari; M Mohebali; Z Zarei; M Aryayipour; Mr Eshraghian; Eb Kia; S Shodajei; J Abdi; A Rakhshanpour; Mb Rokni
Journal:  Iran J Parasitol       Date:  2011-08       Impact factor: 1.012

Review 8.  The Seroprevalence of Human Cystic Echinococcosis in Iran: A Systematic Review and Meta-Analysis Study.

Authors:  Reza Shafiei; Saeed Hosseini Teshnizi; Kurosh Kalantar; Maryam Gholami; Golnush Mirzaee; Fatemeh Mirzaee
Journal:  J Parasitol Res       Date:  2016-10-17

9.  The monetary burden of cystic echinococcosis in Iran.

Authors:  Majid Fasihi Harandi; Christine M Budke; Sima Rostami
Journal:  PLoS Negl Trop Dis       Date:  2012-11-29

10.  Seroprevalence of cystic echinococcosis in blood donors in Fars province, southern Iran.

Authors:  Bahador Sarkari; Farshid Hosseini; Samaneh Abdolahi Khabisi; Farzaneh Sedaghat
Journal:  Parasite Epidemiol Control       Date:  2016-12-15
View more
  2 in total

1.  Three cases of brain hydatidosis in North Khorasan, Iran.

Authors:  Reza Shafiei; Saber Raeghi; Fatemeh Jafarzadeh; Mohsen Najjari; Mohammad Amin Ghatee; Azar Shokri
Journal:  Clin Case Rep       Date:  2022-07-22

2.  Serosurvey of Cystic Echinococcosis and Related Risk Factors for Infection in Fars Province, Southern Iran: A Population-Based Study.

Authors:  Ali Reza Safarpour; Mostafa Omidian; Ali Pouryousef; Mohammad Reza Fattahi; Bahador Sarkari
Journal:  Biomed Res Int       Date:  2022-09-05       Impact factor: 3.246

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.